Free Trial

Bremer Bank National Association Grows Position in Oracle Co. (NYSE:ORCL)

Oracle logo with Computer and Technology background

Bremer Bank National Association grew its stake in Oracle Co. (NYSE:ORCL - Free Report) by 934.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,616 shares of the enterprise software provider's stock after purchasing an additional 39,399 shares during the quarter. Bremer Bank National Association's holdings in Oracle were worth $6,098,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in ORCL. Capital & Planning LLC raised its stake in Oracle by 0.5% during the fourth quarter. Capital & Planning LLC now owns 15,727 shares of the enterprise software provider's stock worth $2,621,000 after acquiring an additional 81 shares in the last quarter. Brighton Jones LLC lifted its holdings in shares of Oracle by 189.3% during the fourth quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider's stock worth $25,593,000 after purchasing an additional 100,494 shares during the period. Union Bancaire Privee UBP SA bought a new stake in shares of Oracle in the fourth quarter worth $51,084,000. Revolve Wealth Partners LLC increased its holdings in Oracle by 8.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider's stock valued at $903,000 after purchasing an additional 404 shares during the period. Finally, R Squared Ltd bought a new position in Oracle during the 4th quarter worth $25,000. Institutional investors and hedge funds own 42.44% of the company's stock.

Analysts Set New Price Targets

ORCL has been the subject of several recent research reports. BMO Capital Markets decreased their price target on Oracle from $205.00 to $175.00 and set a "market perform" rating for the company in a research note on Tuesday, March 11th. Stephens started coverage on shares of Oracle in a report on Wednesday, March 19th. They set an "equal weight" rating and a $167.00 price target for the company. Piper Sandler restated a "neutral" rating and issued a $130.00 price target (down previously from $190.00) on shares of Oracle in a research report on Wednesday, April 23rd. KeyCorp reiterated an "overweight" rating and set a $200.00 price objective on shares of Oracle in a research report on Tuesday, March 11th. Finally, Guggenheim restated a "buy" rating and issued a $220.00 target price on shares of Oracle in a report on Thursday, April 3rd. Fourteen equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $174.42.

Read Our Latest Stock Report on ORCL

Insider Activity

In related news, Director Naomi O. Seligman sold 2,000 shares of the stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $145.81, for a total value of $291,620.00. Following the transaction, the director now owns 34,630 shares of the company's stock, valued at $5,049,400.30. This represents a 5.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Leon E. Panetta sold 5,000 shares of the business's stock in a transaction that occurred on Friday, April 11th. The stock was sold at an average price of $129.77, for a total value of $648,850.00. Following the completion of the sale, the director now owns 58,090 shares of the company's stock, valued at $7,538,339.30. The trade was a 7.93% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 27,366 shares of company stock worth $4,015,723 over the last ninety days. Company insiders own 42.20% of the company's stock.

Oracle Stock Performance

Shares of ORCL stock traded down $0.97 during trading on Wednesday, reaching $168.17. 6,372,366 shares of the company's stock traded hands, compared to its average volume of 9,505,016. The firm's 50-day moving average is $145.39 and its 200 day moving average is $160.82. The company has a market capitalization of $470.36 billion, a P/E ratio of 41.12, a PEG ratio of 3.46 and a beta of 1.32. Oracle Co. has a 1 year low of $118.72 and a 1 year high of $198.31. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 5.65.

Oracle (NYSE:ORCL - Get Free Report) last posted its earnings results on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.49 by ($0.02). The company had revenue of $14.13 billion for the quarter, compared to analysts' expectations of $14.40 billion. Oracle had a return on equity of 133.25% and a net margin of 21.16%. The company's revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.41 EPS. Equities research analysts expect that Oracle Co. will post 5 EPS for the current year.

Oracle Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Thursday, April 10th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date was Thursday, April 10th. This is a positive change from Oracle's previous quarterly dividend of $0.40. Oracle's payout ratio is presently 46.95%.

About Oracle

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Further Reading

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Should You Invest $1,000 in Oracle Right Now?

Before you consider Oracle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.

While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
Google’s $32B Move: 3 Cybersecurity Stocks to Watch

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines